249 related articles for article (PubMed ID: 16493060)
1. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
3. Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo.
Kincaid EZ; Wolf AJ; Desvignes L; Mahapatra S; Crick DC; Brennan PJ; Pavelka MS; Ernst JD
J Immunol; 2007 Sep; 179(5):3187-95. PubMed ID: 17709534
[TBL] [Abstract][Full Text] [Related]
4. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization.
Alvarez GR; Zwilling BS; Lafuse WP
J Immunol; 2003 Dec; 171(12):6766-73. PubMed ID: 14662881
[TBL] [Abstract][Full Text] [Related]
7. LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest.
Rampini SK; Selchow P; Keller C; Ehlers S; Böttger EC; Sander P
Microbiology (Reading); 2008 Oct; 154(Pt 10):2991-3001. PubMed ID: 18832305
[TBL] [Abstract][Full Text] [Related]
8. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.
Nagabhushanam V; Solache A; Ting LM; Escaron CJ; Zhang JY; Ernst JD
J Immunol; 2003 Nov; 171(9):4750-7. PubMed ID: 14568951
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN- gamma -induced gene expression by TLR2-dependent and independent pathways.
Lafuse WP; Alvarez GR; Curry HM; Zwilling BS
J Interferon Cytokine Res; 2006 Aug; 26(8):548-61. PubMed ID: 16881865
[TBL] [Abstract][Full Text] [Related]
11. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.
Arko-Mensah J; Julián E; Singh M; Fernández C
Scand J Immunol; 2007 Feb; 65(2):148-57. PubMed ID: 17257219
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.
Simmons DP; Canaday DH; Liu Y; Li Q; Huang A; Boom WH; Harding CV
J Immunol; 2010 Aug; 185(4):2405-15. PubMed ID: 20660347
[TBL] [Abstract][Full Text] [Related]
13. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
14. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
[TBL] [Abstract][Full Text] [Related]
15. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1.
Ting LM; Kim AC; Cattamanchi A; Ernst JD
J Immunol; 1999 Oct; 163(7):3898-906. PubMed ID: 10490990
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-gamma without inhibiting STAT1 function.
Kincaid EZ; Ernst JD
J Immunol; 2003 Aug; 171(4):2042-9. PubMed ID: 12902509
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
20. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
